A Splice of Life Science Marketing

Brand investment rises while performance tactics get commoditised - but will marketing teams shift budget or stick to old metrics? Shownotes: Strategic intent and operational reality diverge. Roxana's challenge cuts through the optimism: "We've tried everything, and then AI came, and everything seems to be for naught." That's not burnout, that's crisis. This episode is for life science marketing a...

Your buyer has already decided before they ever speak with you. The question isn't whether you can persuade them—it's whether you've made it easy for them to justify choosing you. This episode is for life science product managers and marketers in biotech, medtech, and diagnostics who want to close the gap between what customers say and what they actually do. Matt and Jasmine unpack the uncomfortab...

Life science marketers must navigate six major shifts in 2026 while knowing when AI helps and when human presence is non-negotiable. |AI can scale research, but delegating presence has hidden costs. Life science marketers face six seismic shifts in 2026 that demand human judgement. This episode is for marketing and product managers in biotech, medtech and diagnostics navigating the tension between...

The conversation begins with a wrap-up of the season and a recap of the SAMPS event, highlighting the energy of in-person events, the human-centered approach to AI adoption, and the importance of continuous learning and improvement in AI utilization. Takeaways In-person events foster high-energy networking and conversations AI adoption requires a human-centered approach Continuous learning and imp...